Damien Vasseur

18PUBLICATIONS
206CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsEpigenetics (incl. genome methylation and epigenomics)Liquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jul 13, 2026
Role of ctDNA Tumor Fraction in Selecting Immunotherapy Based Regimens in Advanced Non-small Cell Lung Cancer.

|Apr 17, 2026
Transcription Factor Subtype Governs Response and Resistance to DLL3-Directed T-Cell Engagement in Small Cell Lung Cancer.

|Feb 03, 2026
Recurrent Resistance Mutations to Lirafugratinib Inform Treatment Sequencing in FGFR2-Driven Tumors.

Francesco Facchinetti, Antoine Hollebecque, Rémy Barbé

|Jan 09, 2026
SNAP: Streamlined Nextflow Analysis Pipeline for Immunoprecipitation-Based Epigenomic Profiling of Circulating Chromatin.

Ze Zhang, Paulo Da Silva Cordeiro, Surya B Chhetri

|Dec 10, 2025
Anti-Epidermal Growth Factor Receptor Therapy in EGFR-Amplified Esophagogastric Cancers: An Underestimated Efficacy.

Marine Valéry, Damien Vasseur, Alexandre Megherbi

|Apr 16, 2025
BRAF Kinase Domain Duplication as a Potential On-Target Resistance Mechanism After Dabrafenib-Trametinib Therapy in a Patient With BRAFV600E-Mutated Lung Adenocarcinoma.

Pierre de Priester, Lodovica Zullo, Damien Vasseur

Pageof 3

Frequent Collaborators

10 joint publications

Antoine Hollebecque

7 joint publications

Antoine Italiano

7 joint publications

Benjamin Besse

6 joint publications

Ludovic Lacroix